Posted in | News | Business | Composites

Covestro Expands Its Portfolio with Advancements in CFRTP Composites

Covestro is developing its offerings and capabilities in continuous fiber-reinforced thermoplastic (CFRTP) composites in response to market trends. The Covestro team for thermoplastic composites headed by Lisa Ketelsen is pleased about a new R&D tape line and hybrid injection molding machines for supporting the portfolio expansion to meet an increasing market demand from customers.

 

 

Its Maezio™ brand of CFRTP composites are based on continuous carbon fibers impregnated with thermoplastics like polycarbonates. A new tape line is now commissioned in its Leverkusen laboratory to develop new products with different fiber and resin combinations. Their manufacture will in turn be scaled and commercialized at the production site in Markt Bibart in South Germany.

“We’re witnessing strong market demand for thinner, lighter, and aesthetically competitive products where thermoplastic composites like Maezio™ are making a difference,” says Lisa Ketelsen, head of the thermoplastic composite business of Covestro. “To meet the needs of a growing range of applications we need a broader base of portfolio with different matrix materials and properties. The new tape line in combination with our mass production lines will allow us to do quick iterations and scaling based on market demand.”

New Thermoplastic Composites Under Development

One such product under development is thermoplastic polyurethane (TPU) -based CFRTP, which boasts excellent chemical resistance properties and superior flexibility in a wide temperature range. There’s a strong demand especially from the footwear and sports equipment industries for such a strong and versatile product.

“Thermoplastic composites enable significant increases in production speed for mass production, and their ability to be molded with features and produced to near net shape eliminates the need for many secondary operations,” says Dr.-Ing. Christian Wilms, Head of Technology of the thermoplastic composite business of Covestro. “Also, they are inherently recyclable, making them a genuine answer to the growing need for scalable and sustainable material solutions.”

Stepping Up Capabilities in Processing Know-How

At the same time, new hybrid injection molding machines are commissioned in Covestro’s CFRTP locations in Germany and China to build on processing know-how of complex, three-dimensional composite parts in support of application development across industries. A hybrid injection molding machine combines the thermoforming of semi-finished composite parts with in-mold injection molding – a fully automated one-step processing technology which reduces cycle times and improved productivity of mass-produced composite parts.

Source: http://www.covestro.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Covestro. (2020, June 12). Covestro Expands Its Portfolio with Advancements in CFRTP Composites. AZoM. Retrieved on April 26, 2024 from https://www.azom.com/news.aspx?newsID=51893.

  • MLA

    Covestro. "Covestro Expands Its Portfolio with Advancements in CFRTP Composites". AZoM. 26 April 2024. <https://www.azom.com/news.aspx?newsID=51893>.

  • Chicago

    Covestro. "Covestro Expands Its Portfolio with Advancements in CFRTP Composites". AZoM. https://www.azom.com/news.aspx?newsID=51893. (accessed April 26, 2024).

  • Harvard

    Covestro. 2020. Covestro Expands Its Portfolio with Advancements in CFRTP Composites. AZoM, viewed 26 April 2024, https://www.azom.com/news.aspx?newsID=51893.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.